Navigation Links
Dynavax and Merck & Co., Inc. Announce Partnership to Develop HEPLISAV(TM), an Investigational Hepatitis B Vaccine Currently in Phase 3
Date:11/1/2007

de program support, Dynavax has retained rights to seek strategic partners for future development and commercialization. For more information, please visit http://www.dynavax.com.

About Merck

Merck & Co., Inc. is a global research-driven pharmaceutical company dedicated to putting patients first. Established in 1891, Merck currently discovers, develops, manufactures and markets vaccines and medicines to address unmet medical needs. The Company devotes extensive efforts to increase access to medicines through far-reaching programs that not only donate Merck medicines but help deliver them to the people who need them. Merck also publishes unbiased health information as a not-for-profit service. For more information, visit http://www.merck.com.

Dynavax Forward-looking Statement

This press release contains "forward-looking statements," including statements related to the potential value of payments which may be received pursuant to our collaboration with Merck & Co., Inc., the anticipated development of HEPLISAV, and the future responsibilities of the parties under the collaboration agreements. Actual results may differ materially from those set forth in this press release due to the risks and uncertainties inherent in our business, including difficulties or delays in development, initiation and completion of clinical trials, the results of clinical trials and the impact of those results on the initiation and completion of subsequent trials and issues arising in the regulatory process; achieving our Merck collaborative agreement objectives and obtaining regulatory approval for HEPLISAV; the scope and validity of patent protection and the possibility of claims against us based on the patent rights of others; our ability to obtain additional financing to support our operations; and other risks detailed in the "Risk Factors" section of our Quarterly R
'/>"/>

SOURCE Dynavax Technologies Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. E Merck introduces Livogen Z with zinc sulphate
2. Merck to pay $ 253.5 million to Vioxx victim family
3. Merck and Takeda to collaborate in the sale of Cancer drug Matuzumab
4. Judgment In Favor Of Merck For Vioxx Drug
5. Merck, ICMR to conduct joint trials on cervical cancer vaccine
6. Merck in the Dock Due To Vioxx
7. Merck Says Januvia Effective In Type 2 Diabetes
8. Dr Reddys Launches Generic Version Of Mercks Proscar Tablets
9. Patency On Two Drugs From Merck & Pfizer’s To Expire Soo
10. Developing Nations to Get Gardasil at Lesser Rates from Merck Soon
11. Acid Test - Glaxos Cervarix, and Mercks Gardasil, Compete
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... York, NY (PRWEB) May 29, 2015 ... USA Today, with a circulation of approximately 250,000 and ... distributed nationally, through a vast social media strategy, and ... outlets. To explore the digital version of the campaign, ... cover of the print publication. Inside, the actress, model ...
(Date:5/29/2015)... May 29, 2015 OncLive proudly announces ... dozen medical pioneers recognized by a panel of eminent ... of cancer treatment. Honorees will be introduced and celebrated ... Award Ceremony, held 8:30-11:00 p.m. CDT at The Chicago ... honorees are being recognized for groundbreaking accomplishments, in fields ...
(Date:5/29/2015)... CA (PRWEB) May 29, 2015 Oaksterdam University, the ... June, this time to host its popular and highly demanded ... 14, and 15 from 10:00 am to 5:30 pm each day. ... Cannabis Job Fair will be held on June 14 from ... Fair will be held at the Plaza Hotel & Casino in ...
(Date:5/29/2015)... 29, 2015 Designed with the versatile ... to create an all new, exclusive line of supplementation ... with the latest and greatest, high impact, result driven ... be effective. The 24/7 Series can be used by ... even the casual fitness enthusiasts. There are no stimulant ...
(Date:5/29/2015)... MN (PRWEB) May 29, 2015 As ... Patio and Metro series outdoor saunas have increased in ... landscaping projects, and work at summer cottages. While ... piqued interest in summer projects a few weeks earlier ... suburban communities with smaller lot sizes tend to prefer ...
Breaking Medicine News(10 mins):Health News:OncLive's 2015 Giants of Cancer Care™ Awards Announced Today 2Health News:OncLive's 2015 Giants of Cancer Care™ Awards Announced Today 3Health News:OncLive's 2015 Giants of Cancer Care™ Awards Announced Today 4Health News:Oaksterdam University to Host Educational Cannabis Seminars and Job Fair in Las Vegas June 12 to 15; Training For Those Wanting To Work in Legal Cannabis Industry 2Health News:Oaksterdam University to Host Educational Cannabis Seminars and Job Fair in Las Vegas June 12 to 15; Training For Those Wanting To Work in Legal Cannabis Industry 3Health News:BPI Sports and Bodybuilding.com Partner Up to Bring an Innovative New Line of Supplements 2Health News:BPI Sports and Bodybuilding.com Partner Up to Bring an Innovative New Line of Supplements 3Health News:As Summer Approaches, Finnleo Notes Increased Interest in Patio and Metro Outdoor Saunas 2
... GMPs and adverse event reportingWASHINGTON, March 2 ... Accountability Office (GAO) of a report on the ... Products Association (NPA) released the following statement from ... Association appreciates having the opportunity to be included ...
... Commission wildlife biologists continue to monitor bat hibernacula, the ... or dying from White Nose Syndrome (WNS) has risen ... Carbondale, Lackawanna County; an abandoned mine near Shickshinny, Luzerne ... and Seawra Cave in Mifflin County."We continue to receive ...
... Increases 72% from Prior YearDUBLIN, Calif., March 2 ... company dedicated to the discovery and development of novel ... quarter and year ended December 31, 2008. The Company ... of $2.6 million, or $0.04 per share, compared with ...
... March 2 Align Technology, Inc. (Nasdaq: ... of Invisalign Teen(TM) for non-adult, comprehensive orthodontic treatment. ... and demonstrated effectiveness of the Invisalign(R) system, with ... of permanent teeth, and root-movement control - issues ...
... HOLLYWOOD, Calif., March 2 IPC The Hospitalist Company, Inc. (Nasdaq: ... today announced financial results for the fourth quarter and full year ... , Net revenue ... area net revenue growth of 19% , ...
... and T-shirts are likely to drink more or become binge ... All those T-shirts, hats and other items promoting alcoholic beverages ... fashion statement. , , Teens who own such merchandise are ... new study contends. , The Dartmouth scientists who did the ...
Cached Medicine News:Health News:Natural Products Association Comments on New GAO Report on Regulation of Dietary Supplements 2Health News:WNS Identified at Six Sites in Pennsylvania 2Health News:SuperGen Reports 2008 Fourth Quarter and Year-End Financial Results 2Health News:SuperGen Reports 2008 Fourth Quarter and Year-End Financial Results 3Health News:SuperGen Reports 2008 Fourth Quarter and Year-End Financial Results 4Health News:SuperGen Reports 2008 Fourth Quarter and Year-End Financial Results 5Health News:SuperGen Reports 2008 Fourth Quarter and Year-End Financial Results 6Health News:SuperGen Reports 2008 Fourth Quarter and Year-End Financial Results 7Health News:SuperGen Reports 2008 Fourth Quarter and Year-End Financial Results 8Health News:SuperGen Reports 2008 Fourth Quarter and Year-End Financial Results 9Health News:SuperGen Reports 2008 Fourth Quarter and Year-End Financial Results 10Health News:SuperGen Reports 2008 Fourth Quarter and Year-End Financial Results 11Health News:SuperGen Reports 2008 Fourth Quarter and Year-End Financial Results 12Health News:Align Technology Announces International Availability of Invisalign Teen(TM) 2Health News:Align Technology Announces International Availability of Invisalign Teen(TM) 3Health News:IPC The Hospitalist Company Reports Record Fourth Quarter and Full Year 2008 Results 2Health News:IPC The Hospitalist Company Reports Record Fourth Quarter and Full Year 2008 Results 3Health News:IPC The Hospitalist Company Reports Record Fourth Quarter and Full Year 2008 Results 4Health News:IPC The Hospitalist Company Reports Record Fourth Quarter and Full Year 2008 Results 5Health News:IPC The Hospitalist Company Reports Record Fourth Quarter and Full Year 2008 Results 6Health News:IPC The Hospitalist Company Reports Record Fourth Quarter and Full Year 2008 Results 7Health News:IPC The Hospitalist Company Reports Record Fourth Quarter and Full Year 2008 Results 8Health News:IPC The Hospitalist Company Reports Record Fourth Quarter and Full Year 2008 Results 9Health News:IPC The Hospitalist Company Reports Record Fourth Quarter and Full Year 2008 Results 10Health News:IPC The Hospitalist Company Reports Record Fourth Quarter and Full Year 2008 Results 11Health News:IPC The Hospitalist Company Reports Record Fourth Quarter and Full Year 2008 Results 12Health News:Alcohol-Branded Apparel Linked to Adolescent Drinking 2Health News:Alcohol-Branded Apparel Linked to Adolescent Drinking 3Health News:Alcohol-Branded Apparel Linked to Adolescent Drinking 4
(Date:5/28/2015)... -- Eli Lilly and Company (NYSE: LLY ) announced today ... for up to $1.6 billion aggregate principal amount of certain ... who tendered, and did not validly withdraw, their notes on ... time, on May 27, 2015 (the early tender date), ... to receive the total consideration. The total consideration for each ...
(Date:5/28/2015)... DUBLIN , May 28, 2015 /PRNewswire/ ... ) has announced the addition of Jain ... and Companies"  to their offering.  ... interference (RNAi) or gene silencing involves the ... inside the cell, this material is processed ...
(Date:5/28/2015)... May 28, 2015 AlloSource ®, ... cellular, bone, skin and soft-tissue allografts for use ... patient healing, today announced that AlloWrap® DS, its ... to the high-cost reimbursement category. ... and their patients," said Kimberly French , ...
Breaking Medicine Technology:Lilly Announces the Pricing Terms of Its Cash Tender Offer for Up to $1.6 Billion Aggregate Principal Amount of Its Outstanding Debt Securities 2Lilly Announces the Pricing Terms of Its Cash Tender Offer for Up to $1.6 Billion Aggregate Principal Amount of Its Outstanding Debt Securities 3Lilly Announces the Pricing Terms of Its Cash Tender Offer for Up to $1.6 Billion Aggregate Principal Amount of Its Outstanding Debt Securities 4Lilly Announces the Pricing Terms of Its Cash Tender Offer for Up to $1.6 Billion Aggregate Principal Amount of Its Outstanding Debt Securities 5Global RNAi Market Report 2015-2024 - Technologies, Markets and Companies 2Global RNAi Market Report 2015-2024 - Technologies, Markets and Companies 3AlloSource Announces Milestone In Reimbursement For AlloWrap DS 2
... WEBSTER, Texas, Nov. 10, 2011 IDEV Technologies, Incorporated ... for the company,s 6 French (6Fr) SUPERA VERITAS Transhepatic ... for sale outside the U.S. earlier this year, is ... the unique SUPERA stent, currently cleared in the U.S. ...
... Vascular Designs, Inc., a medical device manufacturing company, today ... FDA marketing clearance in 2009 – is now in ... in the treatment of liver cancer. The IsoFlow™ Infusion ... target and isolate areas within the body where the ...
Cached Medicine Technology:IDEV Technologies Receives FDA Clearance for Its SUPERA VERITAS® 6 French Stent Delivery System 2Breakthrough Cancer Treatment Now in Use at UC Davis Medical Center 2
Codman periosteal elevators, sharp, length 8" (203 mm), blade width 3/16" (5 mm)....
Iowa University periosteal elevator, blade width 11/16" (17 mm), length 7 1/4" (184 mm)....
Cushing periosteal elevators, rounded edge, sharp, wide, blade width 5/8" (16 mm), length 7 1/4" (184 mm)....
Lederer periosteal elevators....
Medicine Products: